31 Mar 2021
Assets18.40
Total Income30.44
Profit After Tax0.66
NET Worth5.89
Reserves and Surplus4.81
Total Borrowing3.04
Open 15th May 2024 · Close 17th May 2024 · Listing 23rd May 2024
The shares listed at ₹155.10, a 59.90% move from the issue price. Quest Laboratories is a SME IPO with an issue size of ₹43.16 crore, proposed for listing on NSE SME. The offer opens on 15th May 2024 and closes on 17th May 2024. The issue structure includes a fresh issue of ₹40.95 crore. The current listing schedule points to 23rd May 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1200 | ₹116,400 |
| Object | Amount |
|---|---|
| Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility | ₹26.00 Cr |
| Funding Working Capital Requirements of the Company | ₹10.00 Cr |
| General corporate purposes | ₹3.38 Cr |
| KPI | Dec 31, 2023 |
|---|---|
| ROE | 34.03% |
| ROCE | 41.86% |
| Debt / Equity | 0.20% |
| RoNW | 34.03% |
| PAT Margin | 12.48% |
| Price to Book Value | 4.59 |
| Expense | Amount |
|---|---|
| Book Running Lead Manager Fees including underwriting commission | ₹2.25 Cr |
| Brokerage, selling commission and upload fees | ₹0.01 Cr |
| Registrars to the issue | ₹0.02 Cr |
| Legal Advisors | ₹0.02 Cr |
| Advertising and marketing expenses | ₹0.03 Cr |
| Printing and stationery expenses | ₹0.01 Cr |
| Others, if any (market making, depositories, marketing fees, consultancy, secretarial, peer review etc.) | ₹1.41 Cr |
| Regulators Including Stock Exchanges | ₹0.04 Cr |